Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 8, 2024F1000ResearchOpen Access

Quantitative assessment of the lipiodol staining after transarterial chemoembolization for hepatocellular carcinoma: can it predict tumor recurrence?

View Full Paper
Ask AI
Bookmark
Share

Authors

TWTunyarat WattanasatesiriThammasat UniversityPFPatcha FaimettaWAWirana AngthongThammasat University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wattanasatesiri et al. (2024) studied this question.

synapsesocial.com/papers/68e61196b6db6435875a4719https://doi.org/10.12688/f1000research.147694.1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response2019 · 52 citations
  2. 2Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma2002 · 2,643 citations
  3. 3Transarterial Chemoembolization for Hepatocellular Carcinoma: Volumetric and Morphologic CT Criteria for Assessment of Prognosis and Therapeutic Success—Results from a Liver Transplantation Center2000 · 167 citations
  4. 4Comparison of CT Findings with Resected Specimens After Chemoembolization with Iodized Oil for Hepatocellular Carcinoma2000 · 232 citations
  5. 5Baseline tumor Lipiodol uptake after transarterial chemoembolization for hepatocellular carcinoma: identification of a threshold value predicting tumor recurrence2017 · 14 citations